We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AMRUTANJAN.NSE

Price
632.05
Stock movement down
-3.85 (-0.61%)
Company name
Amrutanjan Health Care Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
18.27B
Ent value
19.04B
Price/Sales
4.45
Price/Book
6.13
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
38.44
Forward P/E
-
PEG
-
EPS growth
12.94%
1 year return
-5.94%
3 year return
-9.62%
5 year return
10.67%
10 year return
11.38%
Last updated: 2025-04-12

DIVIDENDS

AMRUTANJAN.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E38.44
Price to OCF579.29
Price to FCF579.29
Price to EBITDA72.09
EV to EBITDA75.16

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.45
Price to Book6.13
EV to Sales4.63

FINANCIALS

Per share

Loading...
Per share data
Current share count28.90M
EPS (TTM)16.44
FCF per share (TTM)1.09

Income statement

Loading...
Income statement data
Revenue (TTM)4.11B
Gross profit (TTM)1.89B
Operating income (TTM)492.40M
Net income (TTM)475.20M
EPS (TTM)16.44
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)46.08%
Operating margin (TTM)11.98%
Profit margin (TTM)11.57%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash70.73M
Net receivables0.00
Total current assets3.06B
Goodwill0.00
Intangible assets20.99M
Property, plant and equipment0.00
Total assets3.83B
Accounts payable533.50M
Short/Current long term debt22.14M
Total current liabilities753.96M
Total liabilities848.07M
Shareholder's equity2.98B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)31.53M
Capital expenditures (TTM)0.00
Free cash flow (TTM)31.53M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity15.96%
Return on Assets12.42%
Return on Invested Capital15.94%
Cash Return on Invested Capital1.06%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open640.90
Daily high641.05
Daily low624.95
Daily Volume7K
All-time high992.05
1y analyst estimate-
Beta0.74
EPS (TTM)16.44
Dividend per share-
Ex-div date18 Feb 2025
Next earnings date-

Downside potential

Loading...
Downside potential data
AMRUTANJAN.NSES&P500
Current price drop from All-time high-36.29%-12.89%
Highest price drop-60.16%-56.47%
Date of highest drop4 Sep 20139 Mar 2009
Avg drop from high-26.21%-11.07%
Avg time to new high51 days12 days
Max time to new high1107 days1805 days
COMPANY DETAILS
AMRUTANJAN.NSE (Amrutanjan Health Care Limited) company logo
Marketcap
18.27B
Marketcap category
Large-cap
Description
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; dental gel; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, Southeast Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Employees
634
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found